Arylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase
US7223794B2 · kind B2 · utility
0Cited by
5References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 26, 2002 |
| Grant date | May 29, 2007 |
| Priority date | — |
| Expiry date | Jul 26, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D261/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There are provided novel compounds of formula (I), wherein R1, R2, R3, T, U, X, Y, V and W are as defined in the specification, and pharmaceutically acceptable salts thereof, and enantiomers and racemates thereof; together with processes for their preparation, compositions containing them and their use in therapy. The compounds are inhibitors of nitric oxide synthase and are thereby particularly useful in the treatment or prophylaxis of inflammatory disease and pain
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.